tbuckley/cabot-search huggingface dataset:
A MRI Prospective Survey on Cardiac and Hepatic Iron and Cardiac Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine versus Deferasirox
Authors: Alessia Pepe, Antonella Meloni, Giuseppe Rossi, Domenico Giuseppe D'Ascola, Marcello Capra, Aldo Filosa, Paolo Cianciulli, Luciano Prossomariti, Antonella Quarta, Tommaso Casini, Maria Grazia Bisconte, Saveria Campisi, Aurelio Maggio, Cristina Salvatori, Massimo Midiri, Massimo Lombardi, Caterina Borgna-Pignatti
Journal: Blood (2011)
Signatures of Mesenchymal Cell Lineages and Microenvironment Factors Are Dysregulated in High Risk Myeloma
Authors: Shmuel Yaccoby, Pingping Qu, Syed Mehdi, Antje Hoering, Joshua Epstein, Sarah K. Johnson, Frits van Rhee, Maurizio Zangari, Carolina Schinke, Sharmilan Thanendrarajan, Bart Barlogie, Faith E Davies, Gareth J Morgan
Journal: Blood (2016)
Polyclonal IgG4 Hypergammaglobulinemia Associated with Lymphadenopathy and Renal Disease: A Novel Syndrome.
Authors: Emmanuelle Boulanger, Vincent Fuentes, Veronique Meignin, Beatrice Mougenot, Sylvaine Labaume, Michel Cogne, Pierre Aucouturier, Eric Oksenhendler, Jean-Pierre Clauvel, Pierre Ronco, Kaiss Lassoued
Journal: Blood (2004)
Circulating CLL Cells Expressing CD49d Display a Phospho-Proteomic Profile Consistent with a Constitutive Receptor Engagement by Blood-Borne Ligands
Authors: Dania Benedetti, Erika Tissino, Daniela Marconi, Michele Dal Bo, Riccardo Bomben, Tiziana Vaisitti, Silvia Deaglio, Davide Rossi, Gianluca Gaidano, Gabriele Pozzato, Francesco Di Raimondo, Giovanni Del Poeta, Amy VanMeter, Antonella Zucchetto, Virginia Espina, Lance Liotta, Valter Gattei
Journal: Blood (2012)
Capsaicin application for prevention of chemotherapy induced neuropathy from paclitaxel or oxaliplatin, phase II study
Authors: Chutima Upachar, Supatra Kidwisala, Achaporn Petchdee, Sorrapong Manyanont, Orasit Sukreeyapongse, Supachat Chompoonuch
Journal: Annals of Oncology (2019)
Preemptive Therapy of HHV-6 Encephalitis with Foscarnet Sodium for High Risk Patients After Hematopoietic Stem Cell Transplantation.
Authors: Ken Ishiyama, Takumi Hoshino, Toru Sakura, Shuichi Miyawaki, Jun Ozaki, Toshiro Kurokawa, Takashi Yoshida, Go Aoki, Masaki Yamaguchi, Shinji Nakao
Journal: Blood (2009)
Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease
Authors: Stephen Y. Wang, Andy S. L. Tan, Brian Claggett, Alvin Chandra, Sameed Ahmed M. Khatana, Pamela L. Lutsey, Anna Kucharska-Newton, Silvia Koton, Scott D. Solomon, Ichiro Kawachi
Journal: JAMA Cardiology (2019)

Higher income is associated with lower incident cardiovascular disease (CVD). However, there is limited research on the association between changes in income and incident CVD.To examine the association between change in household income and subsequent risk of CVD.The Atherosclerosis Risk In Communities (ARIC) study is an ongoing, prospective cohort of 15 792 community-dwelling men and women, of mostly black or white race, from 4 centers in the United States (Jackson, Mississippi; Washington County, Maryland; suburbs of Minneapolis, Minnesota; and Forsyth County, North Carolina), beginning in 1987. For our analysis, participants were followed up until December 31, 2016.Participants were categorized based on whether their household income dropped by more than 50% (income drop), remained unchanged/changed less than 50% (income unchanged), or increased by more than 50% (income rise) over a mean (SD) period of approximately 6 (0.3) years between ARIC visit 1 (1987-1989) and visit 3 (1993-1995).Our primary outcome was incidence of CVD after ARIC visit 3, including myocardial infarction (MI), fatal coronary heart disease, heart failure (HF), or stroke during a mean (SD) of 17 (7) years. Analyses were adjusted for sociodemographic variables, health behaviors, and CVD biomarkers.Of the 8989 included participants (mean [SD] age at enrollment was 53 [6] years, 1820 participants were black [20%], and 3835 participants were men [43%]), 900 participants (10%) experienced an income drop, 6284 participants (70%) had incomes that remained relatively unchanged, and 1805 participants (20%) experienced an income rise. After full adjustment, those with an income drop experienced significantly higher risk of incident CVD compared with those whose incomes remained relatively unchanged (hazard ratio, 1.17; 95% CI, 1.03-1.32). Those with an income rise experienced significantly lower risk of incident CVD compared with those whose incomes remained relatively unchanged (hazard ratio, 0.86; 95% CI, 0.77-0.96).Income drop over 6 years was associated with higher risk of subsequent incident CVD over 17 years, while income rise over 6 years was associated with lower risk of subsequent incident CVD over 17 years. Health professionals should have greater awareness of the influence of income change on the health of their patients.
Development of Acute Megakaryoblastic Leukemia in Down Syndrome Is Associated with Sequential Epigenetic Changes That Target the Down Syndrome Critical Region on Chromosome 21,
Authors: Maria E Figueroa, Sebastien Malinge, Timothy M Chlon, Yushan Li, Elisabeth Paietta, Hugo F. Fernandez, Martin S. Tallman, Mitchell J Weiss, Stella T Chou, Ari Melnick, John Crispino
Journal: Blood (2011)
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial
Authors: D.R. Cranendonk, B.C. Opmeer, M.A. van Agtmael, J. Branger, K. Brinkman, A.I.M. Hoepelman, F.N. Lauw, J.J. Oosterheert, A.H. Pijlman, S.U.C. Sankatsing, R. Soetekouw, J. Veenstra, P.J. de Vries, J.M. Prins, W.J. Wiersinga
Journal: Clinical Microbiology and Infection (2019)
Long Term Follow-up of Patients Treated with mTOR Inhibitors for Severe Chronic Gvhd Following Allogeneic Stem Cell Transplantation.
Authors: Michael Schleuning, Dirk Judith, Irena Burlakova, Zuzanna Jedlickova, Mansour Heshmat, Herrad Baurmann, Rainer Schwerdtfeger
Journal: Blood (2009)
Value of EVI1 Gene Expression Level in Adult Acute Lymphoblastic Leukemia (ALL): A Study from the Group for Research on Adult ALL (GRAALL)
Authors: Claire Abbal, Raouf Ben Abdelali, Marina Lafage, Françoise Huguet, Thibaut Leguay, Olivier Spertini, Nicolas Boissel, Claude Gardin, Carlos Graux, Jean-Michel Cayuela, Marie-Laure Boulland, Nathalie Grardel, Anne Bouvier, Michel Duchosal, Véronique Lhéritier, Yves Chalandon, Vahid Asnafi, Norbert Ifrah, Hervé Dombret
Journal: Blood (2014)
Bortezomib In Combination with Dexamethasone and Liposome- Adriamycin Chemotherapy Regimen for Relapsed and Refractory Hodgkin Lymphoma: A Case Report
Authors: Yi Li, Gaofeng Zheng, Xiaoyan Han, Jimin Shi, Jingsong He, WenJun Wu, Xiujin Ye, He Huang, Maofang Lin, Zhen Cai
Journal: Blood (2010)
Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD: Accurate or Not?
Authors: Michael G. Collins, Erin L. Symonds, Peter A. Bampton, P. Toby Coates
Journal: Journal of the American Society of Nephrology (2019)

We read with interest the report by Wong et al.1 of the Detecting Bowel Cancer in CKD (DETECT) study of colorectal cancer screening in 1706 patients with CKD. DETECT investigated the test performance characteristics of fecal immunochemical testing (FIT) to detect advanced colorectal neoplasia. The authors reported a high sensitivity (90%) and negative predictive value (99%), with a positivity rate of 22%. Unfortunately, the estimates of sensitivity, specificity, and negative predictive values are unreliable because not all participants had the reference standard (colonoscopy) performed. In DETECT, only participants with a positive FIT were invited for colonoscopy (323 of 1706; 19%). The authors attempted to mitigate verification bias by using clinical follow-up at 2 years as an alternative reference standard. Although this provided colonoscopy outcomes for 98 of 1337 (7%) patients who were FIT negative at baseline, absence of neoplasia was presumed for the other 1239 patients if there were no symptoms or a subsequent positive FIT result. However, advanced neoplasia is usually asymptomatic, and the opportunity to identify it with colonoscopy was limited to a subgroup of patients, most of whom were FIT positive. This results in differential verification bias and inaccurate estimates of neoplasia prevalence, sensitivity, and specificity.2 The high FIT-positive rate (22%) is also notable. DETECT used a relatively low fecal hemoglobin threshold of 10 μg/g (many screening programs use >20 μg/g) in a population where aspirin and anticoagulant use were common. Unsurprisingly, specificity was relatively low (83%). Given the high rate of serious colonoscopy complications observed (1.5%), this gives cause for concern. Further, the data from DETECT give an estimate of sensitivity for advanced adenoma (i.e., excluding the seven cases of cancer) of 89%. This is much higher than published general population studies with low risk of verification bias that used a 10 μg/g threshold (pooled sensitivity, 40%; specificity, 90%),3 and our previous study in patients with CKD (transplant) where all participants had colonoscopy (FIT positivity, 12%; sensitivity, 25%; specificity, 91%; negative predictive value, 90%).4 Such comparisons highlight the likely biased nature of the DETECT estimates. We therefore believe that the reported diagnostic accuracy results from DETECT are misleading. Both sensitivity and negative predictive value are likely overestimated and, unfortunately, the data are insufficient to determine the accuracy of FIT. Without an unbiased estimation of sensitivity, and with the reported high false positivity rate and high colonoscopy complication rate, it remains unclear whether screening with FIT to detect premalignant advanced neoplasia in patients with CKD is appropriate. Disclosures None.
Analysis of Outcome after Autologous Stem Transplantation in Patients with Newly Diagnosed Myeloma: Comparison of Different Induction Regimens.
Authors: Shaji Kumar, Martha Q. Lacy, Angela Dispenzieri, Suzanne R. Hayman, S. Vincent Rajkumar, Steven Zeldenrust, John A. Lust, Philip R. Greipp, Robert A. Kyle, Dennis A. Gastineau, Morie A. Gertz
Journal: Blood (2006)
Leukemia Escape From HLA-Specific T Lymphocyte Pressure in a Recipient of HLA One Locus-Mismatched Bone Marrow Transplantation
Authors: Tomonori Kato, Makoto Murata, Seitaro Terakura, Kyoko Sugimoto, Miho Murase, Tetsuya Nishida, Tomoki Naoe
Journal: Blood (2011)
Sequential Therapy with IMID's in Relapsed-Refractory Multiple Myeloma Patients.
Authors: Tommasina Guglielmelli, Sara Bringhen, Alfredo Berruti, Francesca Gay, Federica Cavallo, Vittorio Montefusco, Mariella Genuardi, Eugenio Piro, Maria Teresa Petrucci, Tommaso Caravita, Massimo Offidani, Paolo Corradini, Mario Boccadoro, Giuseppe Saglio, Antonio Palumbo
Journal: Blood (2009)
Specific Drug Transporter Genotypes Are Significantly Associated with Increased Rates of Major and Complete Molecular Responses In Newly Diagnosed Chronic Myeloid Leukemia Patients Treated with Imatinib – A TOPS Correlative Substudy
Authors: Simona Soverini, Sabrina Angelini, Eleonora Turrini, Matt Burnett, Gloria Ravegnini, Mark Thornquist, Fabrizio Pane, Fabrizio Quarantelli, Timothy P. Hughes, Deborah L. White, Dong-Wook Kim, Harriet Goh, Jerald P. Radich, Lan Beppu, Giuseppe Saglio, Daniela Cilloni, Ilaria Iacobucci, Giovanni Perini, Giorgio Cantelli Forti, Gianantonio Rosti, Alan Hatfield, Michele Baccarani, Patrizia Hrelia, Giovanni Martinelli
Journal: Blood (2010)
The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era
Authors: Kerry J. Savage, Paul R. Yenson, Tamara Shenkier, Richard Klasa, Diego Villa, Ozge Goktepe, Christian Steidl, Graham W. Slack, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood (2012)
Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups.
Authors: Henrik Hasle, Todd Alonzo, Anne Avrignon, Cathrine Behar, Myron Chang, Ursula Creutzig, Alexandra Fischer, Erik Forestier, Alicira Fynn, Jochen Harbott, Christine J. Harrison, Marry van den Heuvel-Eibrink, Gertjan Kaspers, Franco Locatelli, Peter Nöllke, Sophia Polychronopoulou, Yaddanapudi Ravindranath, Bassem Razzouk, Dirk Reinhardt, Natalia N. Savva, Batia Stark, Stefan Suciu, Monika Trebo, Ichiro Tsukimoto, David Webb, Dorota Wojcik, William G. Woods, Martin Zimmermann, Charlotte M. Niemeyer, Susana Raimondi
Journal: Blood (2004)
A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations
Authors: Collin M. Blakely
Journal: Clinical Cancer Research (2019)

The clinical utility of performing tumor genetic testing to assess for alterations beyond the known targetable oncogenes in lung adenocarcinoma is unclear. Analyzing cancer pathway alterations beyond single oncogenic driver mutations in addition to markers of tumor mutation burden and genomic instability may provide additional predictive and prognostic information.See related article by Zhou et al., p. 7475.
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Authors: Vanderson Rocha, Myriam Labopin, Annalisa Ruggeri, Didier Blaise, Bernard Rio, Jan J Cornelissen, Noel Milpied, Luciana Tucunduva, Arnon Nagler, Mohamad Mohty, Eliane Gluckman
Journal: Blood (2012)
EGF Accelerates Hematopoietic Stem Cell Regeneration Following 5-FU Chemotherapy Via G-CSF Receptor Signaling
Authors: Sadhna O. Piryani, Angel Y.F. Kam, Evelyna G. Kliassov, Benny J. Chen, Neil L. Spector, John P. Chute, Nelson J. Chao, Phuong L. Doan
Journal: Blood (2016)
A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.
Authors: Sagar Lonial, Claire Torre, Michelle Hicks, Stephanie Mcmillan, Amelia A. Langston, Christopher R. Flowers, Mary J. Lechowicz, Edmund K. Waller
Journal: Blood (2004)
The Pan- JAK Inhibitor Ruxolitinib Impairs T-Cell Activation, Cytokine Production and Proliferation In Vivo and In Vitro
Authors: Thomas Stuebig, Christine Wolschke, Haefaa Alchalby, Francis Ayuk, Marion Heinzelmann, Ioanna Triviai, Anita Badbaran, York Hildebrandt, Nicolaus Kroeger
Journal: Blood (2013)
The Combination of Velcade, Idarubicin and Melphalan (VIM) Demonstrates Significant Clinical Activity in Relapsed/Refractory Myeloma Patients.
Authors: Faith E. Davies, Muralikrishnan Srikanth, Ping Wu, Matthew W. Jenner, Rita McCormack, Franz Cordero, Géralyn C. Trudel, Gareth Morgan
Journal: Blood (2007)
A Prognostic Index for Extranodal Natural Killer/T Cell Lymphoma after Non-Anthracycline-Based Treatment (PINK-B): Prognostic Index of Natural Killer Cell Lymphoma (PINK) Combined with Serum Beta-2 Microglobulin
Authors: Seyoung Seo, Jung Yong Hong, Dok Hyun Yoon, Jaekyung Cheon, Chan-Sik Park, Jooryung Huh, Yoonse Lee, Sang-wook Lee, Jin-sook Ryu, Won Seog Kim, Seok Jin Kim, Cheolwon Suh
Journal: Blood (2016)
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function
Authors: Michael T. Lam, Simona Coppola, Oliver H.F. Krumbach, Giusi Prencipe, Antonella Insalaco, Cristina Cifaldi, Immacolata Brigida, Erika Zara, Serena Scala, Silvia Di Cesare, Simone Martinelli, Martina Di Rocco, Antonia Pascarella, Marcello Niceta, Francesca Pantaleoni, Andrea Ciolfi, Petra Netter, Alexandre F. Carisey, Michael Diehl, Mohammad Akbarzadeh, Francesca Conti, Pietro Merli, Anna Pastore, Stefano Levi Mortera, Serena Camerini, Luciapia Farina, Marcel Buchholzer, Luca Pannone, Tram N. Cao, Zeynep H. Coban-Akdemir, Shalini N. Jhangiani, Donna M. Muzny, Richard A. Gibbs, Luca Basso-Ricci, Maria Chiriaco, Radovan Dvorsky, Lorenza Putignani, Rita Carsetti, Petra Janning, Asbjorg Stray-Pedersen, Hans Christian Erichsen, AnnaCarin Horne, Yenan T. Bryceson, Lamberto Torralba-Raga, Kim Ramme, Vittorio Rosti, Claudia Bracaglia, Virginia Messia, Paolo Palma, Andrea Finocchi, Franco Locatelli, Ivan K. Chinn, James R. Lupski, Emily M. Mace, Caterina Cancrini, Alessandro Aiuti, Mohammad R. Ahmadian, Jordan S. Orange, Fabrizio De Benedetti, Marco Tartaglia
Journal: The Journal of Experimental Medicine (2019)

Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation due to inadequate restraint of overactivated immune cells and is associated with a variable clinical spectrum having overlap with more common pathophysiologies. HLH is difficult to diagnose and can be part of inflammatory syndromes. Here, we identify a novel hematological/autoinflammatory condition (NOCARH syndrome) in four unrelated patients with superimposable features, including neonatal-onset cytopenia with dyshematopoiesis, autoinflammation, rash, and HLH. Patients shared the same de novo
The impact of the neuro-oncology research radiographer role in the effective facilitation of an advanced imaging study in glioblastoma
Authors: Sharon Fernandez, Louise Murray, Andrew Scarsbrook, David Broadbent, David Shelley, Stuart Currie, Susan Short
Journal: Neuro-Oncology (2019)

Abstract Background A neuro-oncology research radiographer was included in the multi-disciplinary study team (MDT) from the set-up stage of a new advanced imaging study in glioblastoma, as it was envisaged that this would enhance progress and provide better patient-centred care. Aims This pilot study aimed to include 12 participants. This specialist radiographer role was to support recruitment, co-ordinate appointments and monitor patients’ progress. We aimed to ensure that optimal treatment and patient-centred care remained at the forefront of the study pathway. Method Patients were identified and approached by the radiographer prior to consent by a trial investigator. Additional scans were planned prior to radiotherapy (RT), 2 weeks into RT and 6 weeks post RT. The radiographer ensured streamlined appointments and was present during each study visit to liaise with health professionals, provide a specific point of contact with the patient and to ensure continuity. Results 6 patients have been recruited since November 2018. The specialist radiographer has attended 28 study scans to date. Over 40 face-to-face interactions have been undertaken, 30 email communications and 18 telephone consultations. Patient feedback has been extremely positive, all patients convey that they feel supported and value continuity throughout the pathway. Enhanced communication across the entire study team has also guaranteed efficient recruitment. Conclusion The research radiographer has a key role in the multi-disciplinary team delivering this study. Effective liaison between the radiotherapy and imaging departments has been crucial and patients value a consistent point of contact through the study and treatment pathways.
Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort
Authors: Pinkal Desai, Robert Wallace, Matthew Anderson, Abdel Alqwasmi, Barbara V. Howard, Chunyuan Wu, Monica Safford, Lisa W. Martin, Nicolas Schlecht, Simin Liu, Jeremy Cetnar, Dominic Cirillo, Allison Jay, JoAnn E. Manson, Michael S. Simon
Journal: Blood (2013)
In Vivo T Cell Depletion Using Rabbit Derived ATG Leads to An Increased EBV-PTLD Risk Due to An Induced Imbalance Between B and T Cell Recovery Which Is Not Seen After Horse Derived ATG or Alemtuzumab
Authors: C.J.M. Halkes, J.H.F. Falkenburg, H.M. van Egmond, J. Olde Wolbers, C.W.J. Starrenburg, P. van Balen, M. van de Meent, P.A. von dem Borne, W.A.F. Marijt, J.H. Veelken, I Jedema
Journal: Blood (2011)
Dexamethasone Dose Adjustments Seem To Result in Better Efficacy and Improved Tolerability in Patients with Relapsed/Refractory Multiple Myeloma Who Are Treated with Lenalidomide/Dexamethasone (MM009/010 Sub-Analysis).
Authors: Jesus F. San Miguel, Meletios Dimopoulos, Donna Weber, Marta Olesnyckyj, Zhinuan Yu, Jerome Zeldis, Robert Knight, Vincent Rajkumar
Journal: Blood (2007)
Matching-Adjusted Indirect Treatment Comparison of Bosutinib, Dasatinib, Nilotinib and Ponatinib on Survival for Second Line Chronic Phase Chronic Myeloid Leukemia Patients
Authors: Bogdan Muresan, Carla Mamolo, Joseph C. Cappelleri, Mark Shapiro, Rocco J. Crescenzo, Yun Su, Bart Heeg
Journal: Blood (2016)
Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS-Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109
Authors: Kira Gritsman, Robert P. Hasserjian, Taneisha Sinclair, David M. Weinstock, Britta Will, Ulrich Steidl, Karen K. Ballen, Amir T. Fathi, Amit Verma, Dejan Juric, Philip C. Amrein
Journal: Blood (2016)
Human Antibodies with Specificity for the Spacer Domain of ADAMTS13 Are Derived from VH1-69 Germline Genes.
Authors: Wouter Pos, Brenda M. Luken, Johanna Kremer-Hovinga, Ellen A.M. Turenhout, Roy Jefferis, Jing-fei Dong, Rob Fijnheer, Jan Voorberg
Journal: Blood (2007)
Leukemic CD52 Negative Subclones Due to Defective Glycophosphatidyl-Innositol Anchoring Are Common in Acute Precursor B Lymphoblastic Leukemia, Escape Alemtuzumab Therapy, but Display Increased Sensitivity to Rituximab Mediated Complement Dependent Cytotoxicity: a Mechanistic Rationale for Antibody Combination Therapy.
Authors: Bart Nijmeijer, Marianke LJ Van Schie, Henriette maria Goselink, Roelof Willemze, J.H. Frederik Falkenburg
Journal: Blood (2009)
Fludarabine Based Regimen (FLAI) Is an Effective Treatment for Induction of Multidrug Resistant Pgp-Positive Acute Myeloid Leukemia Patients.
Authors: Domenico Russo, Daniela Damiani, Michele Malagola, Antonio De Vivo, Mauro Fiacchini, Giovanni Martinelli, Pier Paolo Piccaluga, Anna Candoni, Angela Michelutti, Renato Fanin, Maurizio Castelli, Nicoletta Testoni, Emanuela Ottaviani, Michela Rondoni, Giancarla Pricolo, Patrizio Mazza, Eliana Zuffa, Alfonso Zaccaria, Donatella Raspadori, Monica Bocchia, Francesco Lauria, Alessandro Bonini, Paolo Avanzini, Luigi Gugliotta, Ivana Pierri, Marco Gobbi, Giuseppe Visani, Michele Baccarani
Journal: Blood (2005)
Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
Authors: Dongli Cai, Jiaming Li, Dingfeng Liu, Shanjuan Hong, Qin Qiao, Qinli Sun, Pingping Li, Nanan Lyu, Tiantian Sun, Shan Xie, Li Guo, Ling Ni, Liping Jin, Chen Dong
Journal: Cellular and Molecular Immunology (2019)
Targeting BH3-Domain Anti-Apoptotic Proteins with GX15-070 Significantly Increases Rituximab-Mediated Antibody Dependent Cellular Cytotoxicity (ADCC) and Complement Mediated Cytotoxicity (CMC) Against B-Cell Lymphomas.
Authors: Francisco J. Hernandez-Ilizaliturri, Seema Bhat, Arshad Iqbal, Scott Olejniczak, Joy Knight, Myron S. Czuczman
Journal: Blood (2006)
The Use of TCR Vβ Spectratype Analysis in Allogeneic Blood and Marrow Transplantation.
Authors: Thea M. Friedman, Deborah D. Hopely, Joshua L. Stern, Joanne Filicko, Bijoyesh Mookerjee, Delores Grosso, Neal Flomenberg, Robert Korngold
Journal: Blood (2004)
Ensuring an Accurate Scientific Record—Retraction and Republication
Authors: Howard Bauchner, Robert M. Golub
Journal: JAMA (2019)

Hanan Aboumatar, MD, MPH; Mohammad Naqibuddin, MBBS, MPH; Suna Chung, MPH; Hina Chaudhry, MPH; Samuel W. Kim, BA; Jamia Saunders, MD, MS; Lee Bone, MPH; Ayse P. Gurses, MS, MPH, PhD; Amy Knowlton, ScD, MPH; Peter Pronovost, MD, PhD; Nirupama Putcha, MD, MHS; Cynthia Rand, PhD; Debra Roter, DrPH; Carol Sylvester, RN, MS; Carol Thompson, MS, MBA; Jennifer L. Wolff, PhD; Judith Hibbard, PhD, MPH, FCCM; Robert A. Wise, MD